XML 136 R57.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Segment Reporting    
Number of operating segments | segment 1  
Less:    
General and administrative $ 12,290 $ 13,528
Equity-based compensation 3,748 4,354
Net loss (33,971) (25,788)
Life science segment    
Segment Reporting    
Grant Income 19,549 24,805
Less:    
Clinical programs 27,675 21,180
R&D Personnel costs 9,672 8,523
Preclinical programs 810 3,503
Manufacturing 2,241 2,890
Other research and development expenses 198 430
General and administrative 9,622 9,844
Equity-based compensation 3,748 4,354
Other segment items $ (446) $ (131)